Global Reach | FEB 9–14 at CPC1 Hanoi
Momentum continues. From FEB 9–14, CPC1 Hanoi Pharmaceutical JSC successfully dispatched five international shipments, marking another active week for our export division.
ARTIFICIAL TEARS BY HA NOI CPC1 PHARMACEUTICAL: 4 GENERATIONS – WHAT’S THE DIFFERENCE?
1st Generation – Simple saline drops
Provide short-term moisture only
Quickly evaporate and require frequent use
2nd Generation – Synthetic polymers (PEG, HPMC, CMC, etc.)
Increase viscosity and remain longer on the ocular surface
Better lubrication than saline, but still limited in healing support
3rd Generation – Natural polymers, especially Hyaluronic Acid (HA)
Excellent water-binding capacity with long-lasting hydration
Forms a protective cushion over the cornea
Supports ocular surface recovery in dry eye or superficial keratitis
4th Generation – Lipid/Emulsion eye drops
Designed for severe evaporative dry eye
Help restore the lipid layer to reduce tear evaporation
The higher the generation, the more comprehensive the hydration and protection.
HA stands out not only for moisturizing, but also for supporting ocular surface stability and comfort.
Phiphos – A 4th-Generation Innovation
Phiphos is developed as a 4th-generation artificial tear with a composition designed to closely mimic natural tears, delivering comfort and optimized performance.
A comprehensive solution:
Hypotonic solution: Helps balance osmotic pressure, particularly important in dry eye conditions associated with elevated tear osmolarity.
Nano-emulsion technology: Forms a protective layer on the ocular surface, helping soothe the eyes and minimize post-application blurring.
Cationic emulsion technology: Acts across all three layers of the tear film, including the negatively charged mucin layer, supporting improved tear film stability.
BFS (Blow-Fill-Seal) technology: Manufactured as sterile, preservative-free single-dose units to enhance safety and reduce preservative-related risks.
Phiphos supports not only symptom relief, but also long-term ocular surface protection.
Join us in exploring the future of ophthalmology.
